完整後設資料紀錄
DC 欄位語言
dc.contributor.authorTzeng, Nian-Shengen_US
dc.contributor.authorChung, Chi-Hsiangen_US
dc.contributor.authorChang, Hsin-Anen_US
dc.contributor.authorChang, Chuan-Chiaen_US
dc.contributor.authorLu, Ru-Banden_US
dc.contributor.authorYeh, Hui-Wenen_US
dc.contributor.authorChiang, Wei-Shanen_US
dc.contributor.authorKao, Yu-Chenen_US
dc.contributor.authorChang, Shan-Yuehen_US
dc.contributor.authorChien, Wu-Chienen_US
dc.date.accessioned2019-04-02T05:58:54Z-
dc.date.available2019-04-02T05:58:54Z-
dc.date.issued2019-01-01en_US
dc.identifier.issn1550-9389en_US
dc.identifier.urihttp://dx.doi.org/10.5664/jcsm.7632en_US
dc.identifier.urihttp://hdl.handle.net/11536/149032-
dc.description.abstractStudy Objectives: This study has investigated the risk of major adverse cardiovascular events (MACEs), including acute myocardial infarction, coronary artery disease, peripheral artery disease, and acute stroke, among children and adolescents (age younger than 20 years) with obstructive sleep apnea (OSA). Methods: In this study, the population-based National Health Insurance Research Database of Taiwan was used to identify patients in whom OSA had been first diagnosed between 2000 and 2015. Children and adolescents with OSA (n = 6,535) were included with 1:3 ratio by age, sex, and index year of control participants without OSA (n = 19,605). The Cox proportional regression model was used to evaluate the risk of MACEs in this cohort study. Results: After a 15-year follow-up, the incidence rate of MACEs was higher in the OSA cohort when compared with the non-OSA control cohort (15.97 and 8.20 per 100,000 person-years, respectively). After adjusting for covariates, the risk of MACEs among children and adolescents with OSA was still significantly higher (hazard ratio = 2.050; 95% confidence interval = 1.312-3.107; P = .010). No MACEs were found in the children and adolescents with OSA who received continuous airway positive pressure treatment or pharyngeal surgery. Conclusions: This study found a significantly higher risk of MACEs in children and adolescents with OSA. These findings strongly suggest that clinicians should provide careful follow-up and medical treatment for children and adolescents with OSA.en_US
dc.language.isoen_USen_US
dc.subjectcohort studyen_US
dc.subjectmajor adverse cardiovascular eventsen_US
dc.subjectNational Health Insurance Research Databaseen_US
dc.subjectsleep apneaen_US
dc.titleObstructive Sleep Apnea in Children and Adolescents and the Risk of Major Adverse Cardiovascular Events: A Nationwide Cohort Study in Taiwanen_US
dc.typeArticleen_US
dc.identifier.doi10.5664/jcsm.7632en_US
dc.identifier.journalJOURNAL OF CLINICAL SLEEP MEDICINEen_US
dc.citation.volume15en_US
dc.citation.spage275en_US
dc.citation.epage283en_US
dc.contributor.department生物資訊及系統生物研究所zh_TW
dc.contributor.departmentInstitude of Bioinformatics and Systems Biologyen_US
dc.identifier.wosnumberWOS:000461416300013en_US
dc.citation.woscount0en_US
顯示於類別:期刊論文